Comment on “Novel cholesterol lowering drugs: Can phase 2/3 clinical trial safety assessments predict cardiovascular event outcome trial efficacy?”

American Heart Journal Plus: Cardiology Research and Practice · Elsevier

Аннотация

Publication date: November 2026 Source: American Heart Journal Plus: Cardiology Research and Practice, Volume 71 Author(s): P.S. Raghu, Ramica Sharma, Manish R. Bhise

Читать у издателя →

Похожие статьи